MANGALAM DRUG A VALUE BUY

WHEN MANGALAM DRUG SALES WAS AROUND 200 CR
ITS PRICE WAS 400 PLUS
NOW IN LAST 2 YEARS SALES GROWTH UP BY 40%
WHILE PRICE GROWTH DOWN BY 36% WITH NEGATIVE RETURN.
EPS GROWTH IN 2 YEARS AROUND 200%
BUT DUE TO PHARMA SECTOR DOWN TREND PRICE WENT DOWN BUT AFTER THIS MANGALAM HAS DONE MANY DEVELOPMENT.

SO MANGALAM DRUG PRICE SHOULD BE UP BY
75% FROM CMP.
FIRST SALES GROWTH 40%
NEXT TO MAINTAIN 36% NEGATIVE RETURN.
OVERALL
MANGALAM DRUG NOW 160
SHOULD BE 280 IN 2017 OR MARCH 2018
AT ANY COST
DISCLAIMER :ITS MY OPINION, CONSULT YOUR FINANCIAL ADVISOR

Author: Atul Singh Stock Market Analyst

Disclaimer: This Blog, its owner, creator / contributor is not a research analyst and expressing opinion only as an individual investor in Indian equities. He/She is not responsible for any loss arising out of any information, post or opinion appearing on this blog. Investors are advised to consult financial consultant before acting on any such information. All information in this blog is posted for personal study, All information posted on blog is as available in public domain.

5 thoughts on “MANGALAM DRUG A VALUE BUY”

  1. Dear sir..price degrowth of 36% ..may be due to 50% promoters pledging or what you think..pls share..will it be ok to enter in this script @ 160 to 170 .. thanks

  2. Atul sir I bought 300 shares @165.40 is it correct price to enter I’d it further correct then at which price I should buy again?????

  3. Very nice and positive advice worth following it. I would like to enter mangalam now at the current price for long term. Will it be ok ??

Leave a Reply

Your email address will not be published. Required fields are marked *